Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial
Condition(s):ObesityLast Updated:September 3, 2012Completed
Hide Studies Not Open or Pending
Condition(s):ObesityLast Updated:September 3, 2012Completed
Condition(s):Medication Adherence; Bipolar DisorderLast Updated:December 30, 2014Completed
Condition(s):Obesity; Weight Gain; Psychotropic Induced Weight GainLast Updated:January 2, 2019Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:November 19, 2020Completed
Condition(s):SchizophreniaLast Updated:February 8, 2018Terminated
Condition(s):Depressive Disorder, Major; Depression; Depressive DisorderLast Updated:April 30, 2020Completed
Condition(s):Psychotic DisordersLast Updated:April 3, 2012Completed
Condition(s):Adverse Effect of Other Antipsychotics and NeurolepticsLast Updated:June 1, 2016Unknown status
Condition(s):Schizophrenia; Schizophrenia Spectrum and Other Psychotic Disorders; Metabolic Syndrome xLast Updated:January 22, 2021Completed
Condition(s):Obesity; Metabolic SyndromeLast Updated:April 12, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.